Interest of a new humanized anti-CD20 antibody in relapsed or refractory LLC

被引：0
|
作者：
Cluzeau, Thomas
机构：
来源：
HEMATOLOGIE | 2008年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：104 / 105
页数：3
相关论文
共 50 条
  • [21] Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
    Arzoo, K
    Sadeghi, S
    Liebman, HA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) : 922 - 924
  • [22] Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results
    Morschhauser, Franck
    Leonard, John P.
    Fayad, Luis
    Coiffier, Bertrand
    Petillon, Marie-Odile
    Coleman, Morton
    Schuster, Stephen J.
    Dyer, Martin J. S.
    Horne, Heather
    Teoh, Nick
    Wegener, William A.
    Goldenberg, David M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3346 - 3353
  • [23] Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)
    Fernando Pinto, Luis
    Candia, Liliana
    Garcia, Patricia
    Ignacio Marin, Juan
    Pachon, Ines
    Espinoza, Luis R.
    Marquez, Javier
    [J]. RESPIRATION, 2009, 78 (01) : 106 - 109
  • [24] Rituximab: An anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura
    Aggarwal, A
    Catlett, JP
    [J]. SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1209 - 1212
  • [25] Anti-CD20 monoclonal antibody in the treatment of refractory autoimmune cytopenias in adults.
    Narat, S
    Gandla, J
    Mehra, AB
    [J]. BLOOD, 2004, 104 (11) : 742A - 742A
  • [26] Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado, J
    Bustos, JG
    Jimenez-Yuste, V
    Garcia, B
    de Paz, R
    Gracia, J
    Villar, A
    Quintana, M
    Hernandez-Navarro, F
    [J]. BLOOD, 2001, 98 (11) : 59B - 59B
  • [27] The design, construction and function of a new chimeric anti-CD20 antibody
    Wang, Yugang
    Feng, Jiannan
    Huang, Ying
    Gu, Xin
    Sun, Yingxun
    Li, Yan
    Shen, Beifen
    [J]. JOURNAL OF BIOTECHNOLOGY, 2007, 129 (04) : 726 - 731
  • [28] Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab
    Schulz, H
    Pels, H
    Schmidt-Wolf, I
    Zeelen, U
    Germing, U
    Engert, A
    [J]. HAEMATOLOGICA, 2004, 89 (06) : 753 - 754
  • [29] Phase I Study of a New Humanized Anti-CD20 Monoclonal Antibody (LY2469298) in Japanese Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Pretreated with Rituximab-Containing Regimen
    Ogura, Michinori
    Tobinai, Kensei
    Uchida, Toshiki
    Kobayashi, Yukio
    Oyama, Takashi
    Watanabe, Takashi
    Suzuki, Tatsuya
    Maruyama, Dai
    Kasai, Masanobu
    Mori, Masakazu
    Matsue, Tomomi
    Cronier, Damien
    Wooldridge, James E.
    Koshiji, Minori
    [J]. BLOOD, 2010, 116 (21) : 1607 - 1607
  • [30] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
12345